InvestorsHub Logo
icon url

cjstocksup

03/22/10 7:17 PM

#1350 RE: Trum #1349

This is why you would want to invest, talk about huge multi bagger potential ahead with a nice low float. Check this out. 03/19/10
Cytta Corp (OTCBB: CYCA) is pleased to announce that Mr. Karl Harz B.Sc. (Marketing), MBA has been appointed Vice President Business Development and has been elected to the Board of Directors to work with Mr. Stephen Spalding the CEO.

Mr. Harz has many years of experience in the identification, negotiation and acquisition of a myriad of projects ranging from technology, real estate and most recently mining and resource. Mr. Harz with his wife Marilyn K. Harz RN, Ph.D. continue to work together in the development of medical products to better manage the healthcare needs of people with chronic conditions in preparation for healthcare reform.

The crucial involvement of Mr. Harz in Cytta allows us to further our mission to discover, acquire and develop technologically advanced products. Mr. Harz's involvement is related to our discussions with a major partner wishing to assist in the implementation of the home based medical testing systems previously acquired by the Company and currently described as the 'Advanced Medical Project.'

Given the interest currently being displayed in the tremendous savings this technology can deliver to the US Healthcare industry by both industry and government alike, and the Company's Officers knowledge of the field, the Company will hereafter be focusing its ongoing efforts upon implementing these technologies.

The Company also wishes to announce, that it will through the license agreement acquired from Lifespan Inc. continue to focus upon becoming the leading provider of Internet based home medical diagnostic and testing products. Additionally, the Company wishes to announce that Dr. Albert Cook BA, MD will not be joining the Board of Directors or serve as Medical Director as previously announced. Additionally, the Company will be ceasing all negotiations regarding the ScreenMD project.

The primary benefits of Cytta's medical model are clinical, resulting in superior patient outcomes, psychosocial, resulting in better patient satisfaction, and economic, resulting in significantly lower costs. The Advanced Medical system is focused upon connecting leading edge home based medical diagnostic and testing equipment securely through any wireless device to the client's Electronic Medical Record portal.

The medical peripherals and devices which the Company seeks to integrate are designed to simplify the collocation of medical data in the home and securely deliver the core medical data to web based medical portals. The system envisaged by the Company allows for easy access, review, and storage by the user and/or their designated medical professionals from anywhere in the world.

The Company seeks to develop its technological expertise, joint venture relationships and strategic alliances to positioned itself to become a leading integrator of Internet based medical diagnostic and testing products utilizing screen based wireless access devices to reach the ever-growing market segment requiring access to "instant medical testing" and "electronic diagnosis" products. Company management envisions explosive growth as the US moves towards more universal access to home based advanced medical evaluation systems and the current Health Care changes being proposed by Congress resolve into functional improvements.